Results 111 to 120 of about 103,351 (342)
Opsoclonus‐Myoclonus: Not Always Paraneoplastic
Movement Disorders Clinical Practice, EarlyView.
Fernanda Lustosa Cabral Gomez +4 more
wiley +1 more source
Managing Dystonia in Partington Syndrome
Abstract Background Bilateral focal hand dystonia is an almost pathognomonic sign of Partington syndrome, frequently accompanied by intellectual disability and oromotor dyspraxia. However, a few studies have focused on the treatment of this focal dystonia, making patient management uncertain.
Emilie Pichon +13 more
wiley +1 more source
Mechanism of Tryptic Activation ofClostridium botulinumType E Toxin [PDF]
Julia Gerwing +2 more
openalex +1 more source
Abstract Background Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches.
Marcela A. Montiel +5 more
wiley +1 more source
PURIFICATION AND ACTIVATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN [PDF]
Julia Gerwing +2 more
openalex +1 more source
Segmental and Multifocal Isolated Dystonias: Similarities and Differences
Abstract Background Whether the traditional distinction between segmental and multifocal dystonia is clinically or scientifically useful remains unclear. Objective To evaluate whether idiopathic isolated adult‐onset segmental and multifocal dystonia can be differentiated based on clinical features other than the contiguity of affected body regions ...
Hyder A. Jinnah +38 more
wiley +1 more source
In Vitro Acetylcholinesterase Inhibition by Type A Botulinum Toxin [PDF]
Rosemarie Marshall, Loyd Y. Quinn
openalex +1 more source
The utility of the htrA, pagC and nirB promoters to direct the expression of the carboxy-terminal (H(C)) fragment of botulinum toxin F (FH(C)) in Salmonella enterica var Typhimurium has been evaluated. Only low levels of serum antibody were induced after
Fairweather, Neil F +4 more
core +1 more source
Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins
Movement Disorders Clinical Practice, EarlyView.
Eleonora Minacapilli +4 more
wiley +1 more source

